Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
42.50
-0.63 (-1.46%)
At close: Jul 15, 2026, 4:00 PM EDT
42.31
-0.19 (-0.45%)
After-hours: Jul 15, 2026, 7:19 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $3.05 billion as of July 15, 2026. Its market cap has increased by 103.04% in one year.
Market Cap
3.05B
Enterprise Value
2.53B
1-Year Change
103.04%
Ranking
Category
Stock Price
$42.50
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $3.05B, an increase of 1,254.26%. That is a compound annual growth rate of 65.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 3.05B | -15.13% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 3.55B |
| Alumis | 3.53B |
| IDEAYA Biosciences | 3.49B |
| Arcutis Biotherapeutics | 3.37B |
| Ultragenyx Pharmaceutical | 3.18B |
| Beam Therapeutics | 3.13B |
| Celldex Therapeutics | 3.04B |
| uniQure | 2.92B |